Search Results - "PANDITHARATNA, Eshini"

Refine Results
  1. 1

    Standardization of the liquid biopsy for pediatric diffuse midline glioma using ddPCR by Li, Daphne, Bonner, Erin R., Wierzbicki, Kyle, Panditharatna, Eshini, Huang, Tina, Lulla, Rishi, Mueller, Sabine, Koschmann, Carl, Nazarian, Javad, Saratsis, Amanda M.

    Published in Scientific reports (03-03-2021)
    “…Diffuse midline glioma (DMG) is a highly morbid pediatric brain tumor. Up to 80% of DMGs harbor mutations in histone H3-encoding genes, associated with poor…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

    The growing role of epigenetics in childhood cancers by Panditharatna, Eshini, Filbin, Mariella G.

    Published in Current opinion in pediatrics (01-02-2020)
    “…Altered epigenetics is central to oncogenesis in many pediatric cancers. Aberrant epigenetic states are induced by mutations in histones or epigenetic…”
    Get full text
    Journal Article
  8. 8

    DIPG-26. Targeted Protein Degradation of LSD1 synergizes with HDAC inhibitors in Diffuse Intrinsic Pontine Glioma by Groves, Andrew, Poetschke, Rebecca, Mire, Hafsa, Panditharatna, Eshini, Guzman, Maria Tarazona, Qi, Jun, Filbin, Mariella

    Published in Neuro-oncology (Charlottesville, Va.) (03-06-2022)
    “…Diffuse intrinsic pontine glioma (DIPG) remains one of the most lethal brain tumors in all of childhood with no effective treatments besides radiation, which…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    PDTM-07. DETECTION OF IDH1 R132H MOSAICISM IN ANAPLASTIC ASTROCYTOMA PATIENTS by Lee, Sulgi, Bornhorst, Miriam, Panditharatna, Eshini, Kambhampati, Madhuri, Nazarian, Javad

    Published in Neuro-oncology (Charlottesville, Va.) (05-11-2018)
    “…Abstract Anaplastic astrocytomas are aggressive cancers of glial cells that present poor prognosis and high recurrence. Heterozygous mutations in IDH1 and IDH2…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    GENE-20. MULTI-GENE MUTATION PROFILING OF PEDIATRIC MIDLINE GLIOMAS USING PATIENT LIQUID BIOPSY by Bonner, Erin, Panditharatna, Eshini, Kambhampati, Madhuri, Virata, Michael, Singh, Priyam, Prados, Michael, Mueller, Sabine, Nazarian, Javad

    Published in Neuro-oncology (Charlottesville, Va.) (23-04-2019)
    “…Abstract INTRODUCTION: Molecular profiling of the tumor genome is critical for diagnosis and clinical management of CNS tumors. In the case of pediatric…”
    Get full text
    Journal Article
  15. 15
  16. 16

    PDTM-42. CROSS-PLATFORM PROFILING OF ctDNA USING ddPCR: STANDARDIZATION OF THE LIQUID BIOPSY FOR PEDIATRIC DIFFUSE MIDLINE GLIOMA by Li, Daphne, Bonner, Erin, Stallard, Stefanie, Panditharatna, Eshini, Huang, Tina, Lulla, Rishi, Koschmann, Carl, Nazarian, Javad, Saratsis, Amanda

    Published in Neuro-oncology (Charlottesville, Va.) (11-11-2019)
    “…Abstract INTRODUCTION Pediatric diffuse midline glioma (DMG) with histone H3 mutations (80%), are highly morbid tumors with poor response to therapy. We…”
    Get full text
    Journal Article
  17. 17

    DIPG-31. TUMOR SURVEILLANCE USING LIQUID BIOME IN PEDIATRIC HIGH GRADE GLIOMAS by Bonner, Erin, Panditharatna, Eshini, Kambhampati, Madhuri, Van Gool, Stefaan, Stuecker, Wilfried, Packer, Roger, Nazarian, Javad

    Published in Neuro-oncology (Charlottesville, Va.) (22-06-2018)
    “…Abstract Immunotherapy is currently being used to treat pediatric brain cancer, though its efficacy in treating patients with diffuse intrinsic pontine glioma…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Abstract 810: Establishing patient derived preclinical in vitro and in vivo models of pediatric brain cancers by Yadavilli, Sridevi, Kambhampati, Madhuri, Gittens, Jamila, Panditharatna, Eshini, Stampar, Mojca, Kilburn, Lindsay B., Magge, Suresh, Packer, Roger J., Nazarian, Javad

    Published in Cancer research (Chicago, Ill.) (01-07-2017)
    “…The recent surge in understanding genomic aberrations of some of the deadliest childhood brain cancers has highlighted the need for robust preclinical models…”
    Get full text
    Journal Article